Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA awards priority review to Bayer's filing for Stivarga as second-line liver cancer treatment

firstwordpharmaJanuary 05, 2017

Tag: Stivarga , liver cancer treatment

PharmaSources Customer Service